Latest Period
Q1 2026
Security Snapshot
Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) Institutional Ownership
CUSIP: 09075F404
13F Institutional Holders and Ownership History from Q4 2024 to Q1 2026
Institutions Reporting
30
Shares (Excl. Options)
870,671
Price
$1.17
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- BNGO on Nasdaq
- Shares outstanding
- 11,229,947
- Price per share
- $1.16
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 870,671
- Total reported value
- $1,018,155
- % of total 13F portfolios
- 0%
- Share change
- -52,033
- Value change
- -$153,994
- Number of holders
- 30
- Price from insider filings
- $1.16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- BNGO - Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 09075F404.
- 30 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 30 to 30 between Q4 2025 and Q1 2026.
- Reported value moved from $1,354,479 to $1,018,155.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 30 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 09075F404?
CUSIP 09075F404 identifies BNGO - Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09075F404:
Significant Owners of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 0% | $1,795,763 | +$171,307 | 1,129,411 | +11% | CVI Investments, Inc. | 31 Dec 2025 |
| Lind Global Fund III LP | 9.4% | -5.5% | $1,669,500 | +$851,703 | 1,050,000 | +104% | Lind Global Fund III LP | 31 Dec 2025 |
| Ayrton Capital LLC | 10% | $903,140 | 528,245 | Ayrton Capital LLC | 30 Sep 2025 | |||
| Lincoln Alternative Strategies LLC | 5.4% | $2,021,250 | 525,000 | Lincoln Alternative Strategies LLC | 17 Sep 2025 | |||
| Iroquois Capital Management, LLC | 5% | -8.2% | $871,362 | -$26,230 | 509,658 | -2.9% | Iroquois Capital Management, LLC | 30 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $1,957,398 | 508,415 | Mitchell P. Kopin | 16 Sep 2025 |
As of 31 Mar 2026, 30 institutional investors reported holding 870,671 shares of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO). This represents 7.8% of the company’s total 11,229,947 outstanding shares.
Institutional Holders of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 870,671 | $1,018,155 | -$153,994 | $1.17 | 30 |
| 2025 Q4 | 885,151 | $1,354,479 | +$972,920 | $1.53 | 30 |
| 2025 Q3 | 244,406 | $417,230 | +$180,899 | $1.71 | 29 |
| 2025 Q2 | 100,433 | $328,973 | +$12,075 | $3.28 | 25 |
| 2025 Q1 | 104,118 | $290,503 | +$210,076 | $2.79 | 27 |
| 2024 Q4 | 198,732 | $57,021 | +$54,382 | $0.29 | 5 |